Pharmacybox Limited
Pharmacybox Limited
Registered number: 08859633
Director's Report and
Unaudited Financial Statements
For The Year Ended
31 January 2023
LAS Accountants LLP
Pharmacybox Limited
Director's Report and Unaudited Financial Statements
For The Year Ended
31 January 2023
Director's Report and Unaudited Financial Statements
| Contents | |
| Page | |
|---|---|
| Company Information | 1 |
| Director's Report | 2 |
| Accountant's Report | 3 |
| Income Statement | 4 |
| Statement of Financial Position | 5 |
| Notes to the Financial Statements | 6—7 |
Pharmacybox Limited
Company Information
For The Year Ended
31 January 2023
Company Information
| Director |
|
| Company Number |
|
| Registered Office | 2 Dahomey Road |
| Streatham | |
| London | |
| SW16 6ND | |
| Accountants |
|
|
|
|
| London | |
| EC3V 3DG | |
Pharmacybox Limited
Company No. 08859633
Director's Report For The Year Ended
31 January 2023
Director's Report
The director presents his report and the financial statements for the year ended
31 January 2023
.
Principal Activity
The company's principal activity in the year continued to be that of pharmaceutical compliance management consultancy activities.
Directors
The director who held office during the year were as follows:
|
|
Statement of Director's Responsibilities
The director is responsible for preparing the Director's Report and the financial statements in accordance with applicable law and regulations.
Company law requires the director to prepare financial statements for each financial year. Under that law the director has elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the director must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing the financial statements the director is required to:
- select suitable accounting policies and then apply them consistently;
- make judgments and accounting estimates that are reasonable and prudent;
- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.
The director is responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. He is also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
The director is responsible for the maintenance and integrity of the corporate and financial information included on the company's website. Legislation in the United Kingdom governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.
Small Company Rules
This report has been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.
On behalf of the board
|
Director
|
|
|
Pharmacybox Limited
Accountant's Report
For The Year Ended
31 January 2023
Accountant's Report
Chartered Accountant's report to the director on the preparation of the unaudited statutory accounts of
Pharmacybox Limited
For The Year Ended 31 January 2023
In order to assist you to fulfil your duties under the Companies Act 2006, I have prepared for your approval the accounts of
Pharmacybox Limited
For The Year Ended 31 January 2023 which comprise the Income Statement, the Statement of Financial Position and the related notes from the company's accounting records and from information and explanations you have given to us.
As a practising member of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at http://www.icaew.com/en/membership/regulations-standards-and-guidance.
This report is made solely to the director of
Pharmacybox Limited
, as a body, in accordance with the terms of our engagement letter signed For The Year Ended 31 January 2023. Our work has been undertaken solely to prepare for your approval the accounts of
Pharmacybox Limited
and state those matters that we have agreed to state to the director of
Pharmacybox Limited
, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than
Pharmacybox Limited
and its director, as a body, for our work or for this report.
It is your duty to ensure that
Pharmacybox Limited
has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit or loss of
Pharmacybox Limited
. You consider that
Pharmacybox Limited
is exempt from the statutory audit requirement for the year.
We have not been instructed to carry out an audit of the accounts of
Pharmacybox Limited
. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the financial statements.
| Signed |
|
|
|
|
No.1 Royal Exchange
London
EC3V 3DG
Pharmacybox Limited
Income Statement
For The Year Ended
31 January 2023
Income Statement
| 2023 | 2022 | |||
|---|---|---|---|---|
| Notes | £ | £ | ||
| TURNOVER |
|
|
||
| GROSS PROFIT |
|
|
||
| Administrative expenses |
( |
( |
||
| OPERATING PROFIT |
|
|
||
| Other interest receivable and similar income |
|
|
||
| PROFIT BEFORE TAXATION |
|
|
||
| Tax on Profit |
( |
( |
||
| PROFIT AFTER TAXATION BEING PROFIT FOR THE FINANCIAL YEAR |
|
|
||
The notes on pages 6 to 7 form part of these financial statements.
Pharmacybox Limited
Statement of Financial Position
As At
31 January 2023
Statement of Financial Position
| 2023 | 2022 | ||||
|---|---|---|---|---|---|
| Notes | £ | £ | £ | £ | |
| CURRENT ASSETS | |||||
| Debtors | 4 |
|
|
||
| Cash at bank and in hand |
|
|
|||
|
|
|
||||
| Creditors: Amounts Falling Due Within One Year | 5 |
( |
( |
||
| NET CURRENT ASSETS (LIABILITIES) |
|
|
|||
| TOTAL ASSETS LESS CURRENT LIABILITIES |
|
|
|||
| NET ASSETS |
|
|
|||
| CAPITAL AND RESERVES | |||||
| Called up share capital | 6 |
|
|
||
| Income Statement |
|
|
|||
| SHAREHOLDERS' FUNDS | 105,202 | 74,097 | |||
On behalf of the board
|
Director
|
|
|
The notes on pages 6 to 7 form part of these financial statements.
Pharmacybox Limited
Notes to the Financial Statements
For The Year Ended
31 January 2023
Notes to the Financial Statements
1.
General Information
Pharmacybox Limited
is a private company, limited by shares, incorporated in England & Wales, registered number
08859633
. The registered office is 2 Dahomey Road, Streatham, London, SW16 6ND.
2.
Accounting Policies
2.1.
Basis of Preparation of Financial Statements
These financial statements have been prepared in accordance with the provisions of Section 1A "Small Entities" of Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland"and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.
The financial statements are prepared in UK sterling, which is the functional currency of the entity. Monetary amounts in these financial statements are rounded to the nearest UK pound.
The principle accounting polices adopted are set below.
2.2.
Going Concern Disclosure
The director has considered the prospect of the business for the next twelve months and beyond and has arrived at a reasonable expectation the company will continue to meet its obligations as they fall due. The director has also pledged their financial support to assist with this if required. On this basis, the director will continue to adopt the going concern basis of accounting in preparing the financial statements.
2.3.
Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.
2.4.
Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.
Current or deferred taxation assets and liabilities are not discounted.
Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.
2.5.
Financial instruments
The company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities like trade and other debtors, creditors, loans from banks and other third parties, loans to related parties and investments in non-puttable ordinary shares.
2.6.
Cash and cash equivalents
Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.
2.7.
Critical Accounting Judgements and Key Sources of Estimation Uncertainty
In the application of the company's accounting policies management is required to make judgements, estimates and assumptions about the carrying value of assets and liabilities that are not readily ascertainable from other sources. The estimates and underlying assumptions are based on historical experience and other factors that are considered to be relevant. Actual outcomes may differ from these estimates.
The estimates and underlying assumptions are reviewed on a continuing basis. Revisions to accounting estimates are recognised in the period in which the estimates are revised.
The key areas of estimation uncertainty that have a significant effect on the amounts recognised in the financial statements are described below:
Accrued Expenditure
The company includes a provision for invoices which are yet to be received from and amounts paid in advance to suppliers.These provisions are estimated based upon the expected values of the invoices which are issued and services received following the period end.
3.
Average Number of Employees
Average number of employees, including directors, during the year was as follows:
| 2023 | 2022 | ||
|---|---|---|---|
| Office and administration |
|
|
|
|
|
|
||
Pharmacybox Limited
Notes to the Financial Statements (continued)
For The Year Ended
31 January 2023
4.
Debtors
| 2023 | 2022 | ||
|---|---|---|---|
| £ | £ | ||
| Due within one year | |||
| Trade debtors |
|
|
|
| Prepayments and accrued income |
|
|
|
|
|
|
||
5.
Creditors: Amounts Falling Due Within One Year
| 2023 | 2022 | ||
|---|---|---|---|
| £ | £ | ||
| Corporation tax |
|
|
|
| Accruals and deferred income |
|
|
|
| Director's loan account |
|
|
|
|
|
|
||
7.
Related Party Transactions
The Directors Loan Account balance of £137 is a current liability, is interest free and repayable on demand.